Nasal polyps are painless, teardrop-shaped growths that form in your nose or sinuses. They’re most common where the sinuses near your eyes and cheekbones drain into your nose. Nasal polyps are not ...

Dupixent can be used for several conditions, once of which is treating ongoing nasal and sinus inflammation due to nasal polyps. It can be used for both adults and certain children. Dupixent is an ...

Nasal polyps are noncancerous soft tissue growths that form in your nasal passages and sinuses. They’re often a result of inflammation from sinusitis, allergens, or other issues. Experts don’t know ...

Nasal polyps are noncancerous growths that can form in the nasal cavity. Although benign, they can have a significant impact on a person’s quality of life. Nasal polyps often occur along with ...

These symptoms can affect nearly every aspect of your daily life, from sleeping to smelling and even breathing. Understandably, that can take a toll on your mental health as well. Here are some of the ...

Although nasal polyps are noncancerous, these soft growths in the lining of your sinuses or nasal passages can worsen if your body's inflammation levels rise. That can lead to uncomfortable symptoms ...

SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...

Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...

For severe chronic rhinosinusitis with nasal polyps, novel stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid, the randomized CROWNS-2 trial showed. When ...

CRSwNP often coexists with asthma, complicating treatment and reducing health-related quality of life. Standard therapies for CRSwNP, like nasal irrigation and corticosteroids, often inadequately ...

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...